Dissociated response as a new biomarker of treatment response in neuroendocrine tumors: Results from phase 3 of the RAISE project
Dromain C, Pavel ME, Ronot M, Schaefer N, Mandair D, Gueguen D, Cheng C, Cahane D, Jegou S, Balazard F (2021)
Publication Type: Conference contribution
Publication year: 2021
Journal
Publisher: WILEY
City/Town: HOBOKEN
Pages Range: 119-119
Conference Proceedings Title: JOURNAL OF NEUROENDOCRINOLOGY
Authors with CRIS profile
Involved external institutions
Owkin
France (FR)
Royal Free Hospital
United Kingdom (GB)
Ipsen Pharma
France (FR)
Lausanne University Hospital / Centre hospitalier universitaire vaudois (CHUV)
Switzerland (CH)
Beaujon Hospital / Hôpital Beaujon
France (FR)
France (FR)
Royal Free Hospital
United Kingdom (GB)
Ipsen Pharma
France (FR)
Lausanne University Hospital / Centre hospitalier universitaire vaudois (CHUV)
Switzerland (CH)
Beaujon Hospital / Hôpital Beaujon
France (FR)
How to cite
APA:
Dromain, C., Pavel, M.E., Ronot, M., Schaefer, N., Mandair, D., Gueguen, D.,... Balazard, F. (2021). Dissociated response as a new biomarker of treatment response in neuroendocrine tumors: Results from phase 3 of the RAISE project. In JOURNAL OF NEUROENDOCRINOLOGY (pp. 119-119). HOBOKEN: WILEY.
MLA:
Dromain, C., et al. "Dissociated response as a new biomarker of treatment response in neuroendocrine tumors: Results from phase 3 of the RAISE project." Proceedings of the 18th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease HOBOKEN: WILEY, 2021. 119-119.
BibTeX: Download